Zobrazeno 1 - 1
of 1
pro vyhledávání: '"on behalf of the DURIGAST—PRODIGE 59 Investigators/Collaborators"'
Autor:
Camille Evrard, Thomas Aparicio, Emilie Soularue, Karine Le Malicot, Jérôme Desramé, Damien Botsen, Farid El Hajbi, Daniel Gonzalez, Come Lepage, Olivier Bouché, David Tougeron, on behalf of the DURIGAST—PRODIGE 59 Investigators/Collaborators
Publikováno v:
Biomedicines, Vol 10, Iss 5, p 1211 (2022)
Efficacy of immune checkpoint inhibitors (ICI) as monotherapy in 2nd line treatment for gastric or gastro-oesophageal junction (GEJ) adenocarcinoma is low, with no evaluation of efficacy and safety of ICI combined with chemotherapy. The DURIGAST PROD
Externí odkaz:
https://doaj.org/article/e5f33636db76484d82559bf48a274df7
